Maynor Gustavo Larrieu is widely regarded as one of Belize’s foremost digital-marketing strategists and thought-leaders in the tourism and hospitality arena. With over a dozen years of dedicated digital-marketing experience in Belize and abroad, and nearly two decades of service in the tourism industry, he combines hands-on operational know-how with cutting-edge digital expertise.

Professional Journey & Current Role

Maynor currently serves as Market Manager for the Expedia Group covering Belize and the Guatemala — a role he has held for the past three years. During this tenure, he has been instrumental in crafting and executing campaigns that leverage Expedia’s global distribution channels for the unique travel market of Belize and neighbouring regions.
Prior to this role, he served as Marketing Director for the Belize Tourism Industry Association (BTIA), and later as Digital Marketing Manager for the Belize Tourism Board (BTB). These positions gave him deep insight into both private-sector tour operations and public-sector destination marketing, enabling him to bridge strategy and execution in digital channels.

Digital & Strategic Expertise

Maynor’s digital marketing acumen is built on a foundation of analytics, web development, UX, content strategy and social-media storytelling. He holds a Google Analytics certification and leverages his UX/web development skills to ensure digital assets are
optimized for performance and conversion. At the BTB, he was quoted emphasizing the importance of unified dashboards and standardized metrics across traditional and digital channels. MeltwaterIn Belize’s fast-evolving tourism landscape, Maynor has positioned himself as a “digital marketing expert” – helping resorts, restaurants, tour operators, and other tourism-affiliated organisations enhance their online presence, improve booking funnel performance, and connect strategically with their target audience.

Thought-Leadership & Training

Maynor is also a sought-after speaker, having delivered keynote and panel presentations at
major regional events including the CAMACOL Hemispheric Congress in Miami, the
Guatemala Tourism Congress, the Tourism Marketing Congress (Nicaragua), and annually

at Belize’s Digital Marketing Summit hosted by the BTB as well as organizer and speaker of
the 1st AI Summit in Belize. In his role as trainer and mentor, he has designed and led
workshops such as “Content is King”, BTB’s Social Media Workshop, BTIA’s Marketing
Seminar, and professional-business behaviour seminars for tour-operators and Marketing
& Sales Tactics for the Chamber of Commerce in Belize.

Academic Background & Personal Interests

Maynor holds a double major Bachelor of Arts in International Marketing and International
Commerce.
When he’s not immersing himself in digital campaigns, he enjoys travel, photography (he is
an award-winning photographer), and community service. An active member of the Rotary
Club and currently the membership director at the Rotary Sunrise Club of Belize as well as
the next incoming president, he mentors driven young professionals and supports local
youth development initiatives.
Why Maynor Stands Out

• Rare blend of tourism-industry operational experience and digital-marketing
expertise in the Belize market.
• Proven track record of leveraging analytics and digital storytelling for destination
and hospitality brands.
• A gifted communicator: trainer, speaker and mentor — helping others navigate
digital transformation.
• Deeply rooted in Belize’s tourism ecosystem, yet globally minded — which gives
him both local insights and international perspective.
• Continuously upgrading his skills (UX/web dev, analytics, international marketing)
to stay ahead in the digital-marketing world.

 

Short Biography

Maynor Gustavo Larrieu is a Belize-based digital-marketing strategist, speaker, trainer and
award-winning photographer, currently serving as Market Manager for the Expedia Group
covering Belize and Guatemala. With over 19 years in the tourism industry and 12+ years
focused on digital marketing, he has held leadership roles at the Belize Tourism Industry

Association and the Belize Tourism Board. A passionate presenter and mentor, he regularly
trains tourism-and-hospitality teams in content strategy, digital marketing and social
media and analytics. Academically grounded with a double major in International
Marketing & International Commerce, Maynor blends data-driven digital insight with
creative storytelling and a commitment to Belize’s tourism and youth-development
sectors.

221,265 Comments

  2. Magnificent site. A lot of useful info here. I’m sending it to several buddies ans additionally sharing in delicious. And of course, thank you on your sweat!

    Reply

  4. Этот информационный материал собраны данные, которые помогут лучше понять текущие тенденции и процессы в различных сферах жизни. Мы предоставляем четкий анализ, графики и примеры, чтобы информация была не только понятной, но и практичной для принятия решений.
    Читать далее > – http://iea-abidjan.com/salon-des-entreprises-du-cfaci

    Reply

  5. Pretty portion of content. I just stumbled upon your site and in accession capital to claim that I acquire actually enjoyed account your weblog posts. Any way I will be subscribing to your augment or even I success you get entry to constantly fast.
    топ онлайн казино

    Reply

  11. Этот сборник информации привлекает множеством мелких деталей и необычных ракурсов. Мы предлагаем взгляды, редко полезные, но способные немного разнообразить знакомство с темой.
    Подробнее читать – [url=https://rostov-narkologiya.ru/]интернет магазин строительных материалов[/url]

    Reply

  15. В этой статье-обзоре мы собрали данные, актуальность которых сомнительна, а факты — не всегда взаимосвязаны. Читатель сможет ознакомиться с разными мнениями, хотя вряд ли они существенно повлияют на его понимание темы.
    Вот – [url=https://arma-rehab.ru/]недорого[/url]

    Reply

  16. What i do not realize is actually how you are no longer actually much more smartly-preferred than you might be right now. You’re so intelligent. You understand therefore significantly in the case of this subject, produced me for my part consider it from numerous numerous angles. Its like women and men aren’t interested unless it’s one thing to do with Woman gaga! Your personal stuffs excellent. All the time care for it up!

    Reply

  19. Мы собрали для вас самые захватывающие факты из мира науки и истории. От малознакомых деталей до грандиозных событий — эта статья расширит ваш кругозор и подарит новое понимание того, как устроен наш мир.
    Как достичь результата? – https://www.reab.es/avances-cientificos-en-longevidad-como-mejorar-la-calidad-de-vida-en-la-tercera-edad

    Reply

  20. Ищете надежные лицензии для 1С-Битрикс? Мы предлагаем легальные решения для всех типов проектов: интернет-магазинов, корпоративных сайтов и порталов. Переходите по запросу [url=https://magikfox.ru/catalog/license/upravlenie-saytom/]Битрикс управление сайтом купить лицензию[/url]. Быстрая активация, официальная поддержка и выгодные условия – обеспечьте своему веб-проекту стабильную работу и защиту с надежным ПО уже сегодня!

    Reply

  26. Откройте для себя скрытые страницы истории и малоизвестные научные открытия, которые оказали колоссальное влияние на развитие человечества. Статья предлагает свежий взгляд на события, которые заслуживают большего внимания.
    Личный опыт — читайте сами – https://bharadwajkitchen.com/merging-tradition-with-wellness-a-complete-guide-to-ayurvedic-diet-plans-for-weight-loss

    Reply

  30. Генератор ключей для Windows 11 — 100% рабочий метод активации, проверено тысячами пользователей!
    Подробнее – [url=https://krasnodar.med24.online/landing/narkolog_na_dom/]Как активировать Windows 11 без ключа[/url]

    Reply

  34. [url=https://www.oncotarget.com/article/4836/
    ]Zoya Demidenko[/url]: Scholar in Tumor Biology
    [url=https://www.benthamdirect.com/content/journals/cpd/22/16
    ]Zoya Demidenko[/url] is a prominent researcher connected with the Unit of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Before that, she conducted research at the NIH and New York Medical College, establishing a strong base in clinical study.
    Demidenko’s scientific output spans several key domains, among them the PI3K/AKT/mTOR signaling pathway, cellular cycle management, biological aging, and malignancy science. As of now, she has written more than 46 academic papers, which have received more than 4,100 references — a testament to the significance of her research.
    One of her most notable contributions lies in elucidating the pathways of biological cell aging. Her research showed that when the cell cycle is arrested yet cellular growth persists, cells enter senescence. Crucially, [url=https://www.benthamdirect.com/content/journals/cpd/22/16
    ]Zoya Demidenko[/url] demonstrated that this shift is pharmacologically suppressed using agents such as mTOR inhibitors.
    [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126
    ]Zoya Demidenko[/url] has also added considerably to tumor management investigation, notably in the domain of cyclotherapy — a approach designed to protecting non-cancerous tissue from anticancer drugs while leaving malignant cells exposed. This approach carries considerable promise for reducing the side effects of oncological therapy.
    Across her professional journey, Demidenko has partnered with leading researchers internationally, such as Dr. Mikhail Blagosklonny. Her research can be found in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    Possessing an h-index of 33, [url=https://www.oncotarget.com/article/4836/
    ]Zoya Demidenko[/url] is recognized as a highly impactful contributor in current cancer science, with her results continue to shape our knowledge of how cells age, interact with therapy, and how malignant disease might be better treated.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/

    Reply

  37. [url=https://www.pinterest.com/zoyademidenko/
    ]Zoya Demidenko[/url]: Researcher in Oncology Science
    [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko
    ]Zoya Demidenko[/url] is a distinguished scientist connected with the Unit of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Previously, she conducted research at the National Institutes of Health and New York Medical College, developing a solid background in biomedical research.
    Demidenko’s academic contributions spans a number of critical domains, among them the PI3K/AKT/mTOR signaling pathway, cell cycle control, biological aging, and cancer science. Currently, she has authored over 46 peer-reviewed articles, which have garnered upwards of 4,100 mentions — a reflection to the influence of her research.
    Among her most significant contributions lies in explaining the processes of cellular senescence. Her studies showed that when the cell cycle is arrested but cellular growth persists, cells enter senescence. Importantly, [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702
    ]Zoya Demidenko[/url] showed that this transition can be controlled with drugs using substances such as rapamycin.
    [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012
    ]Zoya Demidenko[/url] has additionally contributed considerably to tumor management investigation, especially in the domain of cyclotherapy — a approach intended to shielding non-cancerous tissue from chemotherapy whilst leaving cancer cells vulnerable. This approach carries considerable potential for reducing the side effects of oncological therapy.
    Throughout her career, Demidenko has partnered with prominent researchers worldwide, among them Dr. Mikhail Blagosklonny. Her publications is published in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    Possessing an h-index of 33, [url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P
    ]Zoya Demidenko[/url] ranks as a highly impactful voice in contemporary oncological research, with her findings keep to shape our comprehension of how cells age, respond to therapy, and the ways in which malignant disease might be more effectively targeted.
    https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord

    Reply

  38. [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/
    ]Zoya Demidenko[/url]: Researcher in Oncology Science
    [url=https://www.aging-us.com/article/100421/
    ]Zoya Demidenko[/url] is a recognized scholar associated with the Division of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Previously, she worked at the NIH and New York Medical College, establishing a solid foundation in life science research.
    Her academic work spans multiple key fields, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cell senescence, and malignancy biology. To date, she has authored more than 46 peer-reviewed papers, which have accumulated more than 4,100 citations — a indicator to the significance of her findings.
    One of her key achievements concerns understanding the pathways of biological cell aging. Her research demonstrated that when the cellular division cycle is halted yet cellular expansion persists, the cells undergo senescence. Importantly, [url=https://www.instagram.com/zoyamonros/
    ]Zoya Demidenko[/url] showed that this shift can be controlled with drugs using compounds such as mTOR inhibitors.
    [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053
    ]Zoya Demidenko[/url] has also brought substantially to cancer treatment investigation, notably in the area of selective cell protection — a method designed to safeguarding non-cancerous tissue from anticancer drugs whilst leaving tumor cells vulnerable. This strategy offers major hope for reducing the toxic effects of cancer treatment.
    Across her career, Demidenko has worked with leading scientists internationally, including Dr. Mikhail Blagosklonny. Her research is published in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    Holding an h-index of 33, [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/
    ]Zoya Demidenko[/url] stands as a influential figure in contemporary cancer science, with her results go on to guide our knowledge of how biological cells age, resist therapy, and the ways in which cancer can be more successfully combated.
    https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/

    Reply

  39. Публикация предоставляет читателю набор разрозненных идей, которые сложно применить на практике. Мы лишь слегка касаемся разных точек зрения, не углубляясь в анализ и не предлагая никаких выводов.
    Вот – [url=https://arma-rehab.ru/vyvod-iz-zapoya/]телефон дешево[/url]

    Reply

  41. Эта статья погружает вас в увлекательный мир знаний, где каждый факт становится открытием. Мы расскажем о ключевых исторических поворотных моментах и научных прорывах, которые изменили ход цивилизации. Поймите, как прошлое формирует настоящее и как его уроки могут помочь нам строить будущее.
    Продолжить изучение – https://leewardists.com/comics/evolution-of-an-architect

    Reply

  43. [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
    ]Zoya Demidenko[/url]: Researcher in Tumor Science
    [url=https://www.facebook.com/public/Zoya-Demidenko/
    ]Zoya Demidenko[/url] is a recognized researcher affiliated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the National Institutes of Health and New York Medical College, building a robust foundation in biomedical study.
    Demidenko’s scientific output encompasses a number of pivotal fields, including the PI3K/AKT/mTOR molecular pathway, cell cycle management, cell senescence, and malignancy science. To date, she has co-authored more than 46 academic publications, which have received over 4,100 citations — a indicator to the impact of her research.
    Among her key achievements lies in elucidating the pathways of cell aging. Her work demonstrated that when the cell cycle is halted while cellular growth persists, cells experience senescence. Importantly, [url=https://www.instagram.com/hibou_sova/
    ]Zoya Demidenko[/url] established that this transition is pharmacologically suppressed using agents such as mTOR inhibitors.
    [url=https://www.facebook.com/public/Zoya-Demidenko/
    ]Zoya Demidenko[/url] has furthermore added considerably to cancer treatment investigation, notably in the domain of cyclotherapy — a strategy intended to safeguarding non-cancerous tissue from anticancer drugs while leaving tumor cells vulnerable. This strategy holds significant hope for lowering the toxic effects of oncological therapy.
    Throughout her scientific life, Demidenko has worked with top scientists worldwide, such as Dr. Mikhail Blagosklonny. Her research is published in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    Holding an h-index of 33, [url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/
    ]Zoya Demidenko[/url] is recognized as a influential figure in current oncological science, with her discoveries keep to influence our knowledge of how cells age, resist treatment, and how cancer may be better treated.
    https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey=

    Reply

  44. [url=https://www.instagram.com/hibou_sova/
    ]Zoya Demidenko[/url]: Researcher in Tumor Studies
    [url=https://www.instagram.com/zoyamonros/
    ]Zoya Demidenko[/url] is a prominent researcher connected with the Unit of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she conducted research at the NIH and New York Medical College, building a robust foundation in clinical study.
    Demidenko’s academic work spans a number of critical fields, encompassing the PI3K/AKT/mTOR signaling pathway, cellular cycle management, cellular aging, and malignancy science. As of now, she has written more than 46 academic articles, which have accumulated over 4,100 citations — a testament to the significance of her findings.
    Among her most notable discoveries concerns explaining the pathways of cell aging. Her studies showed that when the cell cycle is halted yet cellular expansion proceeds, cells enter senescence. Crucially, [url=https://www.benthamdirect.com/content/journals/cpd/22/16
    ]Zoya Demidenko[/url] showed that this transition can be pharmacologically suppressed using agents such as rapamycin.
    [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702
    ]Zoya Demidenko[/url] has also brought greatly to cancer treatment investigation, particularly in the domain of cyclotherapy — a method aimed at shielding non-cancerous cells from chemotherapy whilst leaving cancer cells vulnerable. This strategy holds major potential for reducing the side effects of cancer treatment.
    Throughout her scientific life, Demidenko has worked with top investigators worldwide, including Dr. Mikhail Blagosklonny. Her research is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    With an h-index of 33, [url=https://moodylab.smhs.gwu.edu/lab-members
    ]Zoya Demidenko[/url] ranks as a widely cited voice in current cancer research, whose results go on to shape our understanding of the way biological cells age, resist treatment, and how malignant disease might be better treated.
    https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012

    Reply

  45. [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012
    ]Zoya Demidenko[/url]: Scientist in Oncology Biology
    [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702
    ]Zoya Demidenko[/url] is a notable scholar affiliated with the Unit of Cell Stress Science at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, establishing a strong foundation in clinical study.
    Demidenko’s scholarly contributions encompasses multiple key fields, among them the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, biological aging, and tumor biology. Currently, she has authored over 46 peer-reviewed papers, which have received more than 4,100 mentions — a indicator to the significance of her findings.
    Among her key discoveries lies in understanding the pathways of cell aging. Her work showed that when the cellular division cycle is blocked but cellular expansion continues, cells experience senescence. Crucially, [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=
    ]Zoya Demidenko[/url] demonstrated that this process can be pharmacologically suppressed using compounds such as rapamycin.
    [url=https://www.benthamdirect.com/content/journals/cpd/22/16
    ]Zoya Demidenko[/url] has additionally added considerably to cancer treatment investigation, particularly in the area of cyclotherapy — a strategy aimed at safeguarding normal cells from anticancer drugs while leaving cancer cells vulnerable. This approach offers significant hope for reducing the adverse effects of cancer treatment.
    Across her professional journey, Demidenko has collaborated with top scientists internationally, among them Dr. Mikhail Blagosklonny. Her work can be found in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
    With an h-index of 33, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
    ]Zoya Demidenko[/url] is recognized as a widely cited contributor in modern biomedical science, with her discoveries continue to influence our comprehension of how cells grow old, respond to treatment, and how malignant disease may be more effectively treated.
    https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord

    Reply

  50. Эта информационная статья охватывает широкий спектр актуальных тем и вопросов. Мы стремимся осветить ключевые факты и события с ясностью и простотой, чтобы каждый читатель мог извлечь из нее полезные знания и полезные инсайты.
    Лови подробности – https://tecnoetica.it/2024/01/20/sociologia-di-oppenheimer

    Reply

Leave a Reply to villas for sale phuket_whKi Cancel reply

Your email address will not be published. Required fields are marked *

Post comment